Analystreport

Integra lifesciences (NASDAQ: IART) had its price target raised by analysts at Morgan Stanley from $53.00 to $58.00. They now have an "equal weight" rating on the stock.

Integra LifeSciences Holdings Corporation  (IART) 
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.integralife.com